Meet us at Swiss Biotech 2026
Science-Driven Clinical Excellence
Join us at Booth #12 to explore how our AI-powered, patient-centric approach accelerates clinical trials with Quality by Design (QbD), cutting-edge analytics, and seamless regulatory expertise.
See you at Swiss Biotech 2026
Basel, May 4-5, 2026
The Swiss Biotech Day
A global conference, attracting over 2,500 participants from more than 40 countries and fostering international collaboration in biotech innovation.
Join us there
Connect, exchange ideas, and explore cutting-edge developments in R&D, AI, financing, and more, through a dynamic program and the
Global Village platform.
Gayane Nazaretyan
Director of Operations, USA
Marco Villa
Head of Business Operations and Acceleroute
HoursMinutesSeconds
Schedule a meeting with Accelsiors representatives by filling out the form below:
The 5 Pillars of Accelsiors’ Science-Driven Approach
Early-Stage Development & Phase I Solutions
Optimize first-in-human trials with seamless transitions to later phases.
Fully Integrated QbD Clinical Trial Management
Ensure scientifically optimized trials with proactive risk mitigation.
Regulatory Affairs & Strategic Consulting
Navigate global regulatory landscapes with expert guidance.
AI-Powered Data Insights
Leverage real-time, predictive analytics for smarter decision-making.
Patient-Centric Recruitment & Retention Strategies
Optimize enrollment timelines and improve patient retention.
Transform Your Clinical Trials with Science, Strategy, and Speed
- Accelerate Clinical Development
Seamlessly transition from Phase I to later-stage trials with expert-driven strategies. - Risk-Based QbD Trial Management
Proactive mitigation for streamlined, high-quality execution. - Regulatory Expertise That Delivers
Navigate complex global approval pathways efficiently. - AI-Powered Data Insights
Transform raw data into actionable intelligence for real-time decision-making. - Patient-Centric Solutions
Optimize enrollment and retention with tailored engagement strategies.
- Accelerate Clinical Development
